T. Rowe Price Associates’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $583K | Buy |
|
|||||
|
2025
Q4 | $616K | Buy |
|
|||||
|
2025
Q3 | $376K | Buy |
|
|||||
|
2025
Q2 | $289K | Buy |
|
|||||
|
2025
Q1 | $170K | Buy |
|
|||||
|
2024
Q4 | $209K | Buy |
|
|||||
|
2024
Q3 | $381K | Buy |
|
|||||
|
2024
Q2 | $212K | Buy |
|
|||||
|
2024
Q1 | $208K | Buy |
|
|||||
|
2023
Q4 | $159K | Buy |
|
|||||
|
2023
Q3 | $139K | Sell |
|
|||||
|
2023
Q2 | $193K | Sell |
|
|||||
|
2023
Q1 | $108K | Buy |
|
|||||
|
2022
Q4 | $168K | Buy |
|
|||||
|
2022
Q3 | $163K | Buy |
|
|||||
|
2022
Q2 | $87K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.69M | Sell |
|
|||||
|
2020
Q3 | $5.15M | Sell |
|
|||||
|
2020
Q2 | $5.84M | Buy |
|